mircera
roche registration gmbh - methoxy-polyethylenglycol-epoetin beta - anemia; kidney failure, chronic - antianämische präparate - treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adult patients (see section 5. treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in paediatric patients from 3 months to less than 18 years of age who are converting from another erythropoiesis stimulating agent (esa) after their haemoglobin level was stabilised with the previous esa (see section 5.
adjuvant médol
medol - polyethylene-polypropylene glycol - ecemulsionskonzentrat - 77.4 %800 g/l; - netz- und haftmittel ;
komet
leu + gygax ag - nicosulfuron; polyethylene glycerol esters of fatty acids - scsuspensionskonzentrat - 4.1 %40 g/l; ; - herbizid ;
maisnico
schneiter agro ag - nicosulfuron; polyethylene glycerol esters of fatty acids - scsuspensionskonzentrat - 4.1 %40 g/l; ; - herbizid ;
nicogan
cemag handels ag - nicosulfuron; polyethylene glycerol esters of fatty acids - scsuspensionskonzentrat - 4.1 %40 g/l; ; - herbizid ;
nicogan
adama agriculture swiss ag - nicosulfuron; polyethylene glycerol esters of fatty acids - scsuspensionskonzentrat - 4.1 %40 g/l; ; - herbizid ;
nicogan
syngenta agro ag - nicosulfuron; polyethylene glycerol esters of fatty acids - scsuspensionskonzentrat - 4.1 %40 g/l; ; - herbizid ;
mircera 50 ug / 0.3 ml injektionslösung in einer fertigspritze
roche pharma (schweiz) ag - methoxy polyethylene glycol-epoetinum beta - injektionslösung in einer fertigspritze - methoxy polyethylene glycol-epoetinum beta 50 µg, natrii sulfas anhydricus, natrii dihydrogenophosphas monohydricus, mannitolum, poloxamerum 188, acidum hydrochloridum q.s. ad ph, natrii hydroxidum q.s. ad ph, methioninum, aqua ad iniectabile q.s. ad solutionem pro 0.3 ml corresp. natrium 0.62 mg. - stimulierung der erythropoese - biotechnologika
mircera 75 ug / 0.3 ml injektionslösung in einer fertigspritze
roche pharma (schweiz) ag - methoxy polyethylene glycol-epoetinum beta - injektionslösung in einer fertigspritze - methoxy polyethylene glycol-epoetinum beta 75 µg, natrii sulfas anhydricus, natrii dihydrogenophosphas monohydricus, mannitolum, poloxamerum 188, acidum hydrochloridum q.s. ad ph, natrii hydroxidum q.s. ad ph, methioninum, aqua ad iniectabile q.s. ad solutionem pro 0.3 ml corresp. natrium 0.62 mg. - stimulierung der erythropoese - biotechnologika
mircera 100 ug / 0.3 ml injektionslösung in einer fertigspritze
roche pharma (schweiz) ag - methoxy polyethylene glycol-epoetinum beta - injektionslösung in einer fertigspritze - methoxy polyethylene glycol-epoetinum beta 100 µg, natrii sulfas anhydricus, natrii dihydrogenophosphas monohydricus, mannitolum, poloxamerum 188, acidum hydrochloridum q.s. ad ph, natrii hydroxidum q.s. ad ph, methioninum, aqua ad iniectabile q.s. ad solutionem pro 0.3 ml corresp. natrium 0.62 mg. - stimulierung der erythropoese - biotechnologika